Article Information
History
- December 4, 2018.
Article Versions
- You are currently viewing Version 1 of this article (December 4, 2018 - 20:57).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rafael Romero-Garcia1,§,
- Jakob Seidlitz1,
- Kirstie J Whitaker1,
- Sarah E Morgan1,
- Peter Fonagy2,
- Raymond J Dolan3,4,
- Peter B Jones1,5,
- Ian M Goodyer1,5,
- John Suckling1,
- the NSPN Consortium‡,
- Petra E Vértes1,* and
- Edward T Bullmore1,5,6,*
- 1Department of Psychiatry, University of Cambridge, Cambridge, CB2 0SZ, UK
- 2Research Department of Clinical, Educational and Health Psychology, University College London, London, WC1E 6BT, UK
- 3Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, University College London, London, WC1N 3BG, UK
- 4Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, WC1B 5EH, UK
- 5Cambridgeshire and Peterborough NHS Foundation Trust, Huntingdon, PE29 3RJ, UK
- 6ImmunoPsychiatry, Immuno-Inflammation Therapeutic Area Unit, GlaxoSmithKline R&D, Stevenage SG1 2NY, UK
- ↵§Correspondence to: Rafael Romero-Garcia PhD, University of Cambridge, Department of Psychiatry, Sir William Hardy Building, Downing Street, Cambridge CB2 3EB, UK Tel: 1223 764673, Email: rr480{at}cam.ac.uk
↵* These authors contributed equally